Therapeutics of 5-HT3 receptor antagonists: Current uses and future directions

Pharmacology and Therapeutics

Volumn 130, Issue 3, 2011, Pages 338-347

  MacHu, Tina K ^a  

^a University of North Texas Health Science Center   (United States)

Author keywords

5 HT; Antagonist; Irritable bowel syndrome; Nausea and vomiting; Serotonin

Indexed keywords

ALOSETRON; DOLASETRON MESILATE; GRANISETRON; ONDANSETRON; PALONOSETRON; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR;

ARTICLE; CHANNEL GATING; CHEMOTHERAPY INDUCED EMESIS; CONSTIPATION; DIZZINESS; DRUG ABUSE; GASTROINTESTINAL MOTILITY; HEADACHE; HUMAN; IRRITABLE COLON; ISCHEMIC COLITIS; LIGAND BINDING; NAUSEA AND VOMITING; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; RADIATION INDUCED NAUSEA AND VOMITING; SYNAPTIC TRANSMISSION; VOMITING; ANIMAL; DRUG EFFECT; FORECASTING; METABOLISM; NAUSEA; PHYSIOLOGY; REVIEW;

ANIMALS; FORECASTING; GASTROINTESTINAL MOTILITY; HUMANS; IRRITABLE BOWEL SYNDROME; NAUSEA; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; VOMITING;

EID: 79955589525     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.02.003     Document Type: Review

References (162)

1. 3 receptor antagonists: an overview of their present status and future potential in cancer-therapy-induced emesis Drugs 42 1991 551 568 (Pubitemid 21920774)
2. M. Aapro 5-HT3 receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment Oncol 69 2005 97 109 (Pubitemid 41376907)
3. A. Aggarawal, T.F. Cutts, T.L. Abell, S. Cardoso, B. Familoni, and J. Bremer Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous abnormalities Gastroenterol 106 1994 945 950 (Pubitemid 24109280)
4. P.L. Andrews, C.J. Davis, S. Bingham, H.I. Davidson, J. Hawthorn, and L. Maskell The abdominal visceral innervation and the emetic reflex: Pathways, pharmacology, and plasticity Can J Physiol Pharmacol 68 1990 325 345 (Pubitemid 20107636)
5. J.M. Barnes, N.M. Barnes, B. Costall, J.W. Ironside, and R.J. Naylor Identification and characterization of 5-hydroxytryptamine3 recognition sites in human brain tissue J Neurochem 53 1989 1787 1793 (Pubitemid 19283648)
6. 3 receptor - The relationship between structure and function Neuropharmacol 56 2009 273 284
7. 3A) and nicotinic acetylcholine receptors: The anomalous binding properties of nicotine Biochem 41 2002 10262 10269 (Pubitemid 34856451)
8. 3 receptor revealed by unnatural amino acid synthesis J Neurosci 24 2004 9097 9104 (Pubitemid 39372253)
9. D. Belelli, J.M. Balcarek, A.G. Hope, J.A. Peters, J.J. Lambert, and T.P. Blackburn Cloning and functional expression of a human 5-Hydroxytryptamine type 3As receptor subunit Mol Pharmacol 48 1995 1054 1062
10. N. Bocquet, L.P. de Carvalho, J. Cartaud, J. Neyton, C. Le Poupon, and A. Taly A prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family Nature 445 2007 116 119 (Pubitemid 46067312)
11. F.G. Boess, L.J. Steward, J.A. Steele, D. Liu, J. Reid, and T.A. Glencourse Analysis of the ligand binding site of the 5-HT3 receptor using site directed mutagenesis: Importance of glutamine 106 Neuropharmacol 36 1997 637 647 (Pubitemid 27272109)
12. C. Bouzat, F. Gumllar, G. Spitzmaul, H.-L. Wang, D. Rayes, and S.B. Hansen Coupling of agonist binding to channel gating in an Ach-binding protein linked to an ion channel Nature 430 2004 896 900 (Pubitemid 39119217)
13. G.W. Boyd, A.I. Doward, E.W. Kirkness, N.S. Millar, and C.N. Connolly Cell surface expression of 5-Hydroxytryptamine type 3 receptors is controlled by an endoplasmic reticulum retention signal J Biol Chem 278 2003 27681 27687 (Pubitemid 36899956)
14. 3 receptors: The role of oligomerization and chaperone proteins Mol Cell Neurosci 21 2002 38 50 (Pubitemid 35178498)
15. 3A/3B receptors Neuropharmacol 41 2001 282 284 (Pubitemid 32728100)
16. L.J. Brandt, W.D. Chey, A.E. Foxx-Orenstein, L.R. Schiller, P.S. Schoenfeld, and B.M. Spiegel An evidence-based systematic review on the management of irritable bowel syndrome Am J Gastroenterol 104 S1 2009 S1 S35
17. K. Brejc, W.J. van Dijk, R.V. Klaassen, M. Schuurmans, J. van Der Oost, and A.B. Smit Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors Nature 411 2001 269 276 (Pubitemid 32467026)
18. A.D. Campbell, R.R. Kohl, and W.J. McBride Serotonin-3 receptor and ethanol-stimulated somatodendritic dopamine release Alcohol 13 1996 569 574 (Pubitemid 26404176)
19. 3 antagonist on drug-induced stimulation of dopamine release Eur J Pharmacol 164 1989 515 519 (Pubitemid 19146960)
20. P.H. Celie, S.E. van Rossum-Fikkert, W.J. van Dijk, K. Brejc, A.B. Smit, and T.K. Sixma Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AchBP crystal structures Neuron 41 2004 841 842
21. S. Chakrapani, T.D. Bailey, and A. Auerbach Gating dynamics of the acetylcholine receptor J Gen Physiol 123 2004 341 356
22. W.A. Corrigall, and K.M. Coen Nicotine self-administration and locomotor activity are not modified by the 5-HT3 antagonists ICS 205-930 and MDL 72222 Pharmacol Biochem Behav 49 1994 67 71 (Pubitemid 24297258)
23. B. Costall, A.M. Domeney, R.J. Naylor, and F.D. Tattersall 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis Neuropharmacol 25 1986 959 961 (Pubitemid 16045969)
24. 3 receptors Curr Drug Targets CNS Neurol Disord 3 2004 27 37 (Pubitemid 38854899)
25. 3A receptor Mol Brain Res 119 2003 207 212 (Pubitemid 37415094)
26. 3B subunit is a major determinant of serotonin receptor function Nature 397 1999 359 363
27. 3-receptor antagonist efficacy in refractory patients? Cancer Chemother Pharmacol 56 2005 231 238 (Pubitemid 40941792)
28. C.D. Dellisanti, Y. Yao, J.C. Stroud, Z.Z. Wang, and L. Chen Crystal structure of the extracellular domain of nAChR α-1bound to α-bungarotoxin at 1.94 Å resolution Nat Neurosci 10 2007 953 962 (Pubitemid 47185209)
29. 3 receptors are membrane ion channels Nature 339 1989 706 709
30. D.A. Drossman The functional gastrointestinal disorders and the Rome II process GUT 45 Suppl. II 1999 II1 II15
31. D.A. Drossman, and D.L. Dumitrascu Rome III: New standard for functional gastrointestinal disorders J Gastrointestin Liver Dis 15 2006 237 241 (Pubitemid 44483091)
32. A.E. Dubin, R. Huvar, M.R. D'Andreas, J. Pyati, J.Y. Zhu, and K.C. Koy The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit J Biol Chem 274 1999 30799 30810
33. S.I. Dworkin, and J.E. Smith Neurobiological aspects of drug-seeking behaviors T. Thompson, P.B. Drews, J.E. Barrett, Advances in behavioral pharmacology Vol. 6 1987 Erlbaum & Assoc Hillsdale, N.J 1 44
34. W. Dyr, and W. Kostowski Evidence that the amygdala is involved in the inhibitory effects of 5-HT3 receptor antagonists on alcohol drinking in rats Alcohol 12 1995 387 391
35. J.L. Eisele′, S. Bertrand, J.L. Galzi, A. Deillers-Thiery, J.-P. Changeux, and D. Bertrand Chimeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities Nature 336 1993 479 483 (Pubitemid 24013884)
36. 3 receptor over-expression enhances ethanol sensitivity in mice Psychopharmacol 144 1999 411 415 (Pubitemid 29307267)
37. 3 receptor over-expression decreases ethanol self administration in transgenic mice Psychopharmacol 140 1998 243 248 (Pubitemid 28538485)
38. E.A. Englemann, Z.A. Rodd, R.L. Bell, and J.M. Murphy The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy. CNS & Neurolog Disord-Drug Targets 7 2008 454 467
39. B.W. Evans, W.K. Clark, D.J. Moore, and P.J. Whorwell Tegaserod for the treatment of irritable bowel syndrome and chronic constipation Cochrane Database Syst Rev 17 2007 CD00396
40. 3 receptor network after 20 years of research - Evolving concepts in management of pain and inflammation E J Pharmacol 560 2007 1 8
41. P.A. Fasching, B. Kollmannsberger, P.L. Strissel, B. Niesler, J. Engel, and H. Kreis Polymorphisms in the novel serotonin subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy J Cancer Res Clin Oncol 134 2008 1079 1086
42. M. Fayyaz, and J.M. Lackner Serotonin receptor modulators in the treatment of irritable bowel syndrome Ther Clin Risk Manag 4 2008 41 48 (Pubitemid 351460929)
43. A.P. Florczyk, J.E. Schurig, and W.T. Bradner Cisplatin-induced emesis in the ferret. A new animal model Cancer Treat Rep 66 1982 187 189 (Pubitemid 12254687)
44. 4 agonists in irritable bowel syndrome: Systematic review and meta-analysis Am J Gastroenterol 104 2009 1831 1843
45. J.R. Fozard, and A.A. Mobarok Blockade of neuronal tryptamine receptors by metoclopramide Eur J Pharmacol 49 1978 109 112 (Pubitemid 9193629)
46. T. Fukushima, T. Ohtsubo, M. Tsuda, Y. Yanagawa, and Y. Hori Facilitatory actions of serotonin type 3 receptors on GABAergic inhibitory synaptic transmission in spinal superficial dorsal horn J Neurophysiol 102 2009 1459 1471
47. J.B. Furness, W.A.A. Kunze, P.P. Bertrand, N. Clerc, and J.C. Bornstein Intrinsic primary afferent neurons of the intestine Prog Neurobiol 54 1998 1 18 (Pubitemid 28049816)
48. J.H. Gaddum Tryptamine receptors J Physiol 119 1953 363 368
49. T.J. Gan Mechanisms underlying postoperative nausea and vomiting and neurotransmitter receptor antagonist-based pharmacotherapy CNS Drugs 21 2007 813 833 (Pubitemid 47443303)
50. E. Gao, N. Bren, T.P. Burghardt, S. Hansen, R.H. Henchman, and P. Taylor Agonist-mediated conformational changes in acetylcholine-binding protein revealed by simulation and intrinsic tryptophan fluorescence J Biol Chem 280 2005 8443 8451 (Pubitemid 40349749)
51. 3H]-LY278584 Brain Res 553 1991 149 154
52. M.D. Gershon Roles played by 5-hydroxytryptamine in the physiology of the bowel (review) Ailment Pharmacol Ther 13 Suppl. 2 1999 15 30 (Pubitemid 29219277)
53. M.D. Gershon Review article: serotonin receptors and transporters - Roles in normal and abnormal gastrointestinal motility Aliment Pharmacol & Ther 20 S7 2004 3 14 (Pubitemid 39657670)
54. 3 receptors in the rat gastrointestinal tract Gastroenterol 123 2002 217 226 (Pubitemid 34747542)
55. S.R. Glaum, P.A. Brookes, K.M. Spyer, and R.J. Miller 5-Hydroxytryptamine-3 receptors modulate synaptic activity in the rat nucleus tractus solitarius in vitro Brain Res 589 1992 62 68
56. R.K. Goyal Targets of the enteric motor neurons: Smooth muscle cells Gut 47 Suppl. IV 2000 IV38 IV39
57. M.J. Gunthorpe, and S.C. Lummis Conversion of the ion selectivity of the 5-HT(3a) receptor from cationic to anionic reveals a conserved feature of the ligand-gated ion channel superfamily J Biol Chem 276 2001 10977 10983 (Pubitemid 38089277)
58. M.C. Hanna, P.A. Davies, T.G. Hales, and E.F. Kirkness Evidence for expression of heteromeric serotonin 5-HT(3) receptors in rodents J Neurochem 75 2000 240 247 (Pubitemid 30418189)
59. 3A receptor reduces alcohol sensitivity Mol Brain Res 142 2005 146 150 (Pubitemid 41681282)
60. 3 receptors in NCB-20 cells and in rat cerebral membranes Alcoholism Clin Exp Res 15 1991 775 778
61. P. Hesketh Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting Cancer Invest 18 2000 163 173 (Pubitemid 30118410)
62. G.A. Higgins, Y. Wang, W.A. Corrigall, and E.M. Sellers Influence of 5-HT3 receptor antagonists and the indirect 5-HT agonist, dexfenfluramine, on heroin self-administration in rats Psychopharmacol 114 1994 611 619 (Pubitemid 24152142)
63. K. Hillsley, and D. Grundy Sensitivity to 5-hydroxytryptamine in different afferent subpopulations within mesenteric nerves supplying the rat jejunum J Physiol (London) 509 3 1998 717 727 (Pubitemid 28306136)
64. 3 antagonist-induced reductions in alcohol drinking Neuropsychopharmacol 29 2004 1807 1813 (Pubitemid 39336792)
65. 3E receptor subunits: Evolution, distribution and function J Neurochem 108 2009 384 396
66. 3A receptor subunits Mol Pharmacol 55 1999 1037 1043 (Pubitemid 29252369)
67. 3 receptor A subunit Eur J Pharmacol 245 1993 187 192 (Pubitemid 23115055)
68. P.J. Hornby Central neurocircuitry associated with emesis Am J Med 111 2001 106S 112S (Pubitemid 34032001)
69. 3 antagonists reduce morphine self-administration in rats Br J Pharmacol 110 1993 1341 1346
70. 3 receptor subunit Neuroreport 5 1993 121 124 (Pubitemid 23349701)
71. 3 and GABA ρ1 receptors lacking the large cytoplasmic M3M4 loop J Gen Physiol 131 2008 137 146 (Pubitemid 351185795)
72. I.T. Jantunen, V.V. Kataja, T.T. Muhonen, and T. Parviainen Effects of granisetron with doxorubicin or epirubicin on ECG intervals Cancer Chemother Pharmacol 37 1996 502 504 (Pubitemid 26054557)
73. 3 receptors in N1E-115 neuroblastoma cells Br J Pharmacol 117 1996 1507 1515 (Pubitemid 26116778)
74. 3A receptor subtype in dog Eur J Pharmacol 538 2006 23 31
75. B.A. Johnson Role of the serotonergic system in the neurobiology of alcoholism: Implications for treatment CNS Drugs 18 2004 1105 1118 (Pubitemid 40007493)
76. B.A. Johnson, N. Ait-Daoud, A.M. Elkashef, E.V. Smith, R. Kahn, and F. Vocci A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence Int J Neuropsychopharmacol 11 2008 1 14
77. 3 receptor blockade: A preliminary study in healthy male volunteers Psychopharmacol 112 1993 142 144 (Pubitemid 23261868)
78. B.A. Johnson, J.D. Roache, N. Ait-Daoud, N.A. Zanca, and M. Velasquez Ondansetron reduces the craving of biologically predisposed alcoholics Psychopharmacol 160 2002 408 413 (Pubitemid 34253283)
79. B.A. Johnson, J.D. Roache, M.A. Javors, C. DiClemente, C.R. Cloninger, and T.J. Prihoda Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial JAMA 284 2000 963 971 (Pubitemid 30659126)
80. B.W. Jones, D.J. Moore, S.M. Robinson, and F. Song A systematic review of tegaserod for treatment of irritable bowel syndrome J Clin Pharmacol 27 2002 343 352 (Pubitemid 35286232)
81. 3 subtype of serotonin receptor in primary cultures of rodent hippocampus Neurosci Lett 174 1994 133 136 (Pubitemid 24199481)
82. 3A receptor model Biochem 45 2006 1099 1105 (Pubitemid 43167177)
83. R. Kaiser, O. Sezen, A. Papies, S. Bauer, C. Schelenz, and P.B. Tremblay Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to P-450 2D5 genotypes J Clin Oncol 20 2002 2805 2811 (Pubitemid 34651509)
84. A.M. Karnovsky, L.F. Gotow, D.D. McKinley, J.L. Piechan, C.L. Ruble, and C.J. Mills A cluster of novel serotonin receptor 3-like genes on human chromosome 3 GENE 319 2003 137 148 (Pubitemid 37346208)
85. T.L. Kash, A. Jenkins, J.C. Kelley, J.R. Trudell, and N.L. Harrison Coupling of agonist binding to channel gating in the GABA(A) receptor Nature 421 2003 272 275 (Pubitemid 36139131)
86. D.L. Keefe The cardiotoxic potential of the 5-HT3 receptor antagonist anti-emetics: Is there cause for concern? Oncologist 7 2002 65 72 (Pubitemid 34151109)
87. 3 receptors Nature 424 2003 321 324 (Pubitemid 36899374)
88. G.J. Kilpatrick, B.J. Jones, and M.B. Tyers Identification and distribution of the 5-HT3 receptors in rat brain using radioligand binding Nature 330 1987 746 748 (Pubitemid 18017268)
89. 3 receptor antagonist, reduces voluntary ethanol consumption in rats Pharmacol Biochem and Behav 41 1992 847 850
90. 3 receptor antagonist ICS 205-930 to inhibit alcohol preference and withdrawal seizures in rats Alcohol 10 1993 369 373 (Pubitemid 23276853)
91. A.L. Kovac Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting Drug Safety 26 2003 227 259 (Pubitemid 36363606)
92. M.G. Kris, P.J. Hesketh, M.R. Somerfield, P. Feyer, R. Clark-Snow, and J.M. Koeller American Society of Clinical Oncology guideline for antiemetics in oncology: Update 2006 J Clin Oncol 24 2006 2932 2947 (Pubitemid 46630595)
93. 3 receptor cDNA and its splice variants from guinea pig Mol Pharmacol 53 1998 202 212 (Pubitemid 28099729)
94. 3H]zacopride as ligands Synapse 10 1992 271 281
95. R.J. Law, R.H. Henchman, and J.A. McCammon A gating mechanism proposed from a simulation of a human α7 nicotinic acetylcholine receptor Proc Natl Acad Sci USA 102 2005 6813 6818 (Pubitemid 40675398)
96. W.Y. Lee, C.R. Free, and S.M. Sine Binding to gating transduction in nicotinic receptors: cys-loop energetically couples to pre-M1 and M2-M3 regions J Neurosci 29 2009 3189 3199
97. W.Y. Lee, and S.M. Sine Principal pathway coupling agonist binding to channel gating in nicotinic receptors Nature 438 2005 167 168
98. D. Lesbros-Pantoflickova, P. Michetti, M. Fried, C. Beglinger, and A.L. Blum Meta-analysis: The treatment of irritable bowel syndrome Aliment Pharmacol Ther 20 2004 1253 1269 (Pubitemid 40040072)
99. K.-P. Lesch, D. Bengel, A. Heils, S.Z. Sabol, B.D. Greenberg, and S. Petri Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Sci. 274 1996 1527 1531 (Pubitemid 26403928)
100. 3a receptor J Biol Chem 283 2008 19301 19313
101. D.M. Lovinger, K.W. Sung, and Q. Zhou Ethanol and trichloroethanol alter gating of 5-HT3 receptor-channels in NCB-20 neuroblastoma cells Neuropharmacol 39 2000 561 570 (Pubitemid 30089306)
102. D.M. Lovinger, and G. White Ethanol potentiation of 5-Hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons Mol Pharmacol 40 1991 263 270
103. S.C.R. Lummis, D.L. Beene, L.W. Lee, H.A. Lester, R.W. Broadhurst, and D.A. Dougherty Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel Nature 438 2005 248 252 (Pubitemid 41599879)
104. 3 receptors expressed in Xenopus laevis oocytes J Pharmacol Exp Ther 271 1994 898 905 (Pubitemid 24377780)
105. N. Manabe, T. Tanaka, J. Hata, H. Kusunoki, and K. Haruma Pathophysiology underlying irritable bowel syndrome - From the viewpoint of dysfunction of autonomic nervous system activity J Sm Musc Res 45 2009 15 23
106. 3 receptor, a serotonin-gated ion channel Sci 254 1991 432 437 (Pubitemid 21917361)
107. H.R. Mertz Drug therapy: Irritable bowel syndrome N Engl J Med 349 2003 2136 2146 (Pubitemid 37464539)
108. W.D. Miner, and G.J. Sanger Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism Br J Pharmacol 88 1986 497 499 (Pubitemid 16066912)
109. 3 receptor: Heterogeneity in distribution and function among species Mol Pharmacol 48 1995 407 416
110. A. Miyazawa, Y. Fujiyoshi, and N. Unwin Structure and gating mechanisms of the acetylcholine receptor pore Nature 423 2003 949 955 (Pubitemid 36806903)
111. 3 receptors Eur J Pharmacol 369 1999 125 132 (Pubitemid 29129549)
112. 3 receptor subunit Eur J Pharmacol 399 2000 97 106 (Pubitemid 30407029)
113. S.A. Monk, K. Desai, C.A. Brady, J.M. Williams, L. Lin, and A. Princivalle Generation of a selective 5-HT3B subunit-recognising polyclonal antibody; Identification of immunoreactive cells in rat hippocampus Neuropharmacol 41 2001 1013 1016 (Pubitemid 34024997)
114. 3 receptor subtype in the rat brain and spinal cord J Comp Neurol 402 1998 385 401 (Pubitemid 28541686)
115. M. Morales, E. Battenberg, L. de Lecea, P.P. Sanna, and F.E. Bloom Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous system Mol Brain Res 36 1996 251 260 (Pubitemid 26095584)
116. 3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon J Neurosci 17 1997 3157 3167 (Pubitemid 27175828)
117. 3 receptors synthesized in the rat CNS and peripheral nervous system J Neurosci 22 2002 6732 6741 (Pubitemid 35386429)
118. B. Niesler, B. Frank, J. Kapeller, and G.A. Rappold Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E GENE 319 2003 101 111 (Pubitemid 36703304)
119. B. Niesler, J. Kapeller, C. Hammer, and G. Rappold Serotonin type3 genes: HTR3A, B, C, D, E Pharmacogenom 9 2008 501 504
120. 3E Mol Pharmacol 72 2007 8 17 (Pubitemid 46998520)
121. 3 receptor using a molecular ruler Biophys J 98 2010 1847 1855
122. K.L. Price, K.S. Bower, A.J. Thompson, H.A. Lester, D.A. Dougherty, and S.C. Lummis A hydrogen bond in Loop A is critical for the binding and function of the 5-HT3 receptor Biochem 47 2008 6370 6377 (Pubitemid 351874228)
123. K.L. Price, and S.C.R. Lummis The role of tyrosine residues in the extracellular domain of the 5-hydroxytryptamine3 receptor J Biol Chem 279 2004 23294 23301 (Pubitemid 38685638)
124. R. Rahimi, S. Nikfar, and M. Abdollahi Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: A meta-analysis of eight randomized, placebo-controlled 12 week trials Clin Ther 30 2008 884 901 (Pubitemid 351802282)
125. 3 receptors J Neurosci 25 2005 9358 9366 (Pubitemid 41464748)
126. 3B receptor subunits by anti-peptide polyclonal antibodies BMC Neurosci 7 2006 27
127. E. Rocha, M. Silva, J.R. Valle, and Z.P. Picarelli A pharmacological analysis of the mode of action of serotonin (5-hydroxytryptamine) upon the guinea pig ileum Br J Pharmacol 8 1953 378 388
128. C. Rojas, M. Stathis, A.G. Thomas, E.B. Massuda, J. Alt, and J. Zhang Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor Anesth Analg 107 2008 469 478
129. 3 receptor expression J Neurosci 17 1997 6629 6638 (Pubitemid 27366615)
130. (3AB) receptors by etomidate, propofol, and pentobarbital Eur J Pharmacol 273 2007 60 64 (Pubitemid 47464221)
131. R.S. Sandler Epidemiology of irritable bowel syndrome in the United States Gastroenterol 99 1990 409 415 (Pubitemid 20219097)
132. G.J. Sanger, and P.L.R. Andrews Treatment of nausea and vomiting: Gaps in our knowledge Auto Neurosci: Basic & Clin 129 2006 3 16 (Pubitemid 44472635)
133. 3 receptor J Biol Chem 278 2003 22709 22715
134. M.A. Schuckit Low level of response to alcohol as a predictor of future alcoholism Am J Psych 151 1994 184 191
135. P.E. Scuderi Pharmacology of antiemetics Int Anesthesiol Clin 41 2003 41 66 (Pubitemid 37296612)
136. A. Sikander, S.V. Rana, and K.K. Prasad Role of serotonin in gastrointestinal motility and irritable bowel syndrome Clin Chim Acta 403 2009 47 55
137. 3 receptor ligand binding domain J Biol Chem 275 2000 5620 5625 (Pubitemid 30115200)
138. 3ab receptors by volatile anesthetics and n-alcohols J Pharmacol Exp Ther 314 2005 338 345 (Pubitemid 41058271)
139. L.J. Steward, F.G. Boess, J.A. Steele, D. Liu, N. Wong, and I.L. Martin Importance of phenylalanine 107 in agonist recognition by the 5-hydroxytryptamine (3A) receptor Mol Pharmacol 57 2000 1249 1255 (Pubitemid 30354398)
140. 3A receptor contributes to the differential actions of 5-Hydroxytryptamine and m-chlorophenylbiguanide Biochem 44 2005 9140 9149 (Pubitemid 40949543)
141. R.M. Swift, D. Davidson, W. Whelihan, and O. Kuznetsov Ondansetron alters human intoxication Biol Psych 40 1996 514 521
142. 3 receptor mRNA Proc Natl Acad Sci USA 90 1993 1430 1434 (Pubitemid 23058186)
143. A.J. Thompson, C.L. Padgett, and S.C. Lummis Mutagenesis and molecular modeling reveal the importance of the 5-HT3 receptor F-loop J Biol Chem 281 2006 16576 16582
144. 3 receptor binding site using modeling and radioligand binding J Biol Chem 280 2005 20476 20482 (Pubitemid 40776747)
145. D.M. Tompkins, A.D. Le, and E.M. Sellers Effect of the 5-HT3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure Psyhcopharmacol 117 1995 479 485
146. P.-B. Tremblay, R. Kaiser, O. Sezer, N. Rosler, C. Schelenz, and K. Possinger Variations in the 5-Hydroxytryptamine 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients J Clin Oncol 21 2003 2147 2155 (Pubitemid 46606363)
147. 3 receptors Ann NY Acad Sci 600 1990 194 200
148. M. Tzvetkov, V. Meineke, E. Oetjen, K. Hirsch-Ernst, and J. Brockmoller Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine GENE 386 2007 52 62 (Pubitemid 44918233)
149. N. Unwin Refined structure of the nicotinic acetylcholine receptor at 4 angstrom resolution J Mol Biol 346 2005 967 989 (Pubitemid 40215523)
150. 3ASR binding site BMC Biochem 3 2002 15
151. K. Vucurovic, T. Gallopin, I. Ferezou, A. Rancillac, P. Chameau, and J.A. van Hooft Serotonin3A receptor subtype as an early and protracted marker of cortical interneuron subpopulations Cer Cor 20 2010 2333 2347
152. S.L. Walsh, and K.A. Cunningham Serotonergic mechanisms involved in the discriminative stimulus, reinforcing, and subjective effects of cocaine Psychopharmacol 130 1997 41 58 (Pubitemid 27107783)
153. J. Walstab, G. Rappold, and B. Niesler 5-HT3 receptors: Role in disease and target of drugs Pharm & Ther 128 2010 146 169
154. P. Werner, E. Kawashima, J. Reid, N. Hussy, K. Lundstrom, and G. Buell Organization of the mouse 5-HT3 receptor gene and functional expression of two splice variants Mol Brain Res 26 1994 233 241
155. K.M. Wozniak, A. Pert, and M. Linnoila Antagonism of 5-HT3 receptors attenuates the effects of ethanol on extracellular dopamine Eur J Pharmacol 187 1990 287 289 (Pubitemid 20323953)
156. 3 receptor onto d-tubocurarine structure Mol Pharmacol 70 2006 571 578 (Pubitemid 44092318)
157. 3 receptor J Biol Chem 274 1999 5537 5541 (Pubitemid 29109202)
158. 3 receptor Mol Pharmacol 68 2005 365 371 (Pubitemid 41058300)
159. L.P.H. Yang, and L.J. Scott Palonosetron: In the prevention of nausea and vomiting Drugs 69 2009 2257 2278
160. 3A receptors Biochem 46 2007 1194 1204 (Pubitemid 46208468)
161. 3A receptors confer partial agonist and antagonist properties to benzylidene analogs of anabaseine J Pharmacol Exp Ther 317 2006 1276 1284 (Pubitemid 43764134)
162. 3 receptor-channels on NCB-20 neuroblastoma cells by favouring and stabilizing the open channel state J Physiol 507 2 1998 335 352 (Pubitemid 28135188)